29.12.2016 Views

NanoViricides, Inc Market Product Pipeline Market Review 2016

Global Markets Direct's, 'NanoViricides, Inc. - Product Pipeline Review - 2016', provides an overview of the NanoViricides, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'NanoViricides, Inc. - Product Pipeline Review - 2016', provides an overview of the NanoViricides, Inc.'s pharmaceutical research and development focus.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>NanoViricides</strong>, <strong>Inc</strong> <strong>Market</strong> <strong>Product</strong> <strong>Pipeline</strong> <strong>Market</strong> <strong>Review</strong><br />

<strong>2016</strong> by Radiant Insights<br />

Summary<br />

Global <strong>Market</strong>s Direct's, '<strong>NanoViricides</strong>, <strong>Inc</strong>. - <strong>Product</strong> <strong>Pipeline</strong> <strong>Review</strong> - <strong>2016</strong>', provides an overview of the<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>.'s pharmaceutical research and development focus.<br />

The report provides comprehensive information on the therapeutics under development by <strong>NanoViricides</strong>, <strong>Inc</strong>.,<br />

complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration<br />

(RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its<br />

complete research and development history and the dormant and discontinued projects.<br />

Global <strong>Market</strong>s Direct's report features investigational drugs from across globe covering over 20 therapy areas and<br />

nearly 3,000 indications. The report is built using data and information sourced from Global <strong>Market</strong>s Direct's<br />

proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor<br />

presentations and featured press releases from company/university sites and industry-specific third party sources.<br />

Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that<br />

all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes<br />

ensure that the most recent developments are captured on a real time basis.<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/nanoviricides-inc-productpipeline-review-<strong>2016</strong><br />

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision<br />

making capabilities and helps to create effective counter strategies to gain competitive advantage.<br />

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.<br />

Scope<br />

- The report provides a snapshot of the pipeline therapeutic landscape of <strong>NanoViricides</strong>, <strong>Inc</strong>.<br />

- The report provides overview of <strong>NanoViricides</strong>, <strong>Inc</strong>. including its business description, key facts, and locations and<br />

subsidiaries<br />

- The report features descriptive drug profiles for the pipeline products which includes, product description,<br />

descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities<br />

- The report covers pipeline products based on various stages of development ranging from pre-registration till<br />

discovery and undisclosed stages<br />

- The report assesses <strong>NanoViricides</strong>, <strong>Inc</strong>.'s pipeline therapeutics based on drug target, mechanism of action (MoA),<br />

route of administration (RoA) and molecule type


- The report features <strong>NanoViricides</strong>, <strong>Inc</strong>.'s out-licensed and partnered product portfolio and summarizes its<br />

dormant and discontinued projects<br />

Reasons To Buy<br />

- Evaluate <strong>NanoViricides</strong>, <strong>Inc</strong>.'s strategic position with total access to detailed information on its product pipeline<br />

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies<br />

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain<br />

competitive advantage<br />

- Identify and understand important and diverse types of therapeutics under development for <strong>NanoViricides</strong>, <strong>Inc</strong>.<br />

- Identify potential new clients or partners in the target demographic<br />

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics<br />

- Devise corrective measures for pipeline projects by understanding <strong>NanoViricides</strong>, <strong>Inc</strong>.'s pipeline depth and focus<br />

of pipeline therapeutics<br />

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most<br />

attractive projects to enhance and expand business potential and scope<br />

Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/nanoviricides-inc-productpipeline-review-<strong>2016</strong>/request-sample<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 5<br />

List of Figures 5<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. Snapshot 6<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. Overview 6<br />

Key Information 6<br />

Key Facts 6<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. - Research and Development Overview 7<br />

Key Therapeutic Areas 7<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. - <strong>Pipeline</strong> <strong>Review</strong> 10<br />

<strong>Pipeline</strong> <strong>Product</strong>s by Stage of Development 10<br />

<strong>Pipeline</strong> <strong>Product</strong>s - Monotherapy 11<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. - <strong>Pipeline</strong> <strong>Product</strong>s Glance 12<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. - Early Stage <strong>Pipeline</strong> <strong>Product</strong>s 12<br />

Preclinical <strong>Product</strong>s/Combination Treatment Modalities 12<br />

Discovery <strong>Product</strong>s/Combination Treatment Modalities 13<br />

<strong>NanoViricides</strong>, <strong>Inc</strong>. - Drug Profiles 14<br />

ADIFBase-I 14<br />

<strong>Product</strong> Description 14<br />

Mechanism of Action 14<br />

R&D Progress 14<br />

DengueCide 15<br />

<strong>Product</strong> Description 15<br />

Mechanism of Action 15<br />

R&D Progress 15<br />

EKCCide-I 16<br />

<strong>Product</strong> Description 16<br />

Mechanism of Action 16<br />

R&D Progress 16<br />

Herpecide 17<br />

<strong>Product</strong> Description 17<br />

Mechanism of Action 17<br />

R&D Progress 17


HIVCide-I 19<br />

<strong>Product</strong> Description 19<br />

Mechanism of Action 19<br />

R&D Progress 19<br />

HIVCide-II 20<br />

<strong>Product</strong> Description 20<br />

Mechanism of Action 20<br />

R&D Progress 20<br />

NVINF-1 21<br />

<strong>Product</strong> Description 21<br />

Mechanism of Action 21<br />

R&D Progress 21<br />

NVINF-2 23<br />

<strong>Product</strong> Description 23<br />

Mechanism of Action 23<br />

R&D Progress 23<br />

Read Complete Report with TOC @ http://www.radiantinsights.com/research/nanoviricides-inc-productpipeline-review-<strong>2016</strong><br />

About Us:<br />

Radiant Insights <strong>Inc</strong>. is a platform for companies looking to meet their market research and business intelligence<br />

requirements. We assist and facilitate organizations and individuals procure market research reports, helping them<br />

in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries<br />

and a host of micro markets. In addition to over extensive database of reports, our experienced research<br />

coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research<br />

solutions.<br />

Contact Details:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

Radiant Insights, <strong>Inc</strong><br />

28 2nd Street,<br />

Suite 3036 San Francisco,<br />

CA 94105 United States<br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Website: http://www.radiantinsights.com/<br />

Email: sales@radiantinsights.com<br />

Visit our Blog: http://chemicalsandmaterialsri.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!